HERON THERAPEUTICS, INC. /DE/ — Director's Dealing 2010

May 26, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AP PHARMA INC /DE/ (APPA)
CIK: 0000818033
Period of Report: 2010-05-20

Reporting Person: TURNBULL GREG (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-05-20	Common Stock	A	95891	—	Acquired	245092	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	175	Indirect

Footnotes

F1: Vesting will occur in equal increments, 1/2 to vest in 6 months from the date of grant and the balance to vest on the day prior to the Company's next Annual Meeting.